ABCB4 and hepatocellular carcinoma: GDC-0449 significantly reduced liver fibrosis and the tumor burden in aged Mdr2-deficient mice that already exhibited advanced liver fibrosis and hepatocellular carcinoma [55] and blocked the growth of tamoxifen-resistant breast cancer cell xenografts in mice [56].